Karen A. Scappaticci

Dr. Scappaticci is an Independent Board Director-Advisor to the Pharmaceutical Industry and Healthcare Organizations. Previously, she was Vice President of Clinical Operations at Pfizer Pharmaceuticals. With over 22 years of experience in the business and development of pharmaceuticals, she has managed large strategic change initiatives and international pharmaceutical drug development programs and operations. Karen has personal experience in over 50 regulatory submissions for new drug NDAs and international filings, supplementary filings, and labeling. She has previously reviewed Clinical Phase I through III portfolios for pharmaceutical companies and is advising pharmaceutical start-up ventures. She also serves on the Boards of The Gaylord Hospital, Inc. and Families and Children Agency Inc. She holds a Ph.D. in neuropharmacology and an MBA in strategic management.

Dr. Scappaticci's direct experience and expertise in pharmaceutical development processes, operations and markets, as well as her governance experience and strategic management skills, are valuable in addressing AlphaVax's immediate operational and manufacturing needs and in rebuilding the composite skills of the Board.